Patient and family experiences inform antidepressant safety information review
An Expert Working Group has completed a review into how the potential risks associated with antidepressant medicines are communicated to patients
An Expert Working Group has completed a review into how the potential risks associated with antidepressant medicines are communicated to patients
This is a work sharing model for the co-ordinated assessment of a generic application that has been filed with multiple Access Consortium agencies.
The MHRA has five top tips to help you stay well through the festive season and beyond
Summary of the latest safety advice for medicines and medical device users
Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information.
Additional funding will allow the MHRA and NICE to continue developing clear, proportionate guidance for digital mental health technologies, supporting safer, more effective tools for people across the UK.
Study provides crucial insights for targeting rapid response strategies and improving polio surveillance worldwide